Guardian Pharmacy Services (NYSE:GRDN) Stock Price Up 1.7% – Time to Buy?

Guardian Pharmacy Services, Inc. (NYSE:GRDNGet Free Report)’s stock price traded up 1.7% on Monday . The company traded as high as $21.61 and last traded at $21.61. 2,268 shares changed hands during trading, a decline of 99% from the average session volume of 155,954 shares. The stock had previously closed at $21.25.

Guardian Pharmacy Services Stock Down 0.7 %

The company has a fifty day moving average of $20.55.

Institutional Investors Weigh In On Guardian Pharmacy Services

Hedge funds have recently made changes to their positions in the business. Wellington Management Group LLP acquired a new position in shares of Guardian Pharmacy Services during the third quarter valued at $8,400,000. Barclays PLC acquired a new position in Guardian Pharmacy Services during the 3rd quarter valued at about $311,000. Virtu Financial LLC bought a new stake in shares of Guardian Pharmacy Services during the 3rd quarter worth about $279,000. Franklin Resources Inc. acquired a new stake in shares of Guardian Pharmacy Services in the 3rd quarter worth approximately $8,575,000. Finally, Investment Research & Advisory Group Inc. bought a new position in shares of Guardian Pharmacy Services in the fourth quarter valued at approximately $34,000.

About Guardian Pharmacy Services

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Recommended Stories

Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.